CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Wang Lai Global Head of R&D | Sale | −841 | $153.75 | $129K | 0 |
| 2024-06-18 | Wu Xiaobin President, COO & GM China | Sale | −1,121 | $153.66 | $172K | 1,506 |
| 2024-06-18 | Wu Xiaobin President, COO & GM China | Sale | −906 | $154.17 | $140K | 600 |
| 2024-06-18 | Wu Xiaobin President, COO & GM China | Sale | −300 | $155.15 | $47K | 300 |
| 2024-06-18 | Wu Xiaobin President, COO & GM China | Sale | −300 | $156.80 | $47K | 0 |
| 2024-06-17 | OYLER JOHN Chief Executive Officer | Sale | −297 | $158.53 | $47K | 984 |
| 2024-06-17 | OYLER JOHN Chief Executive Officer | Sale | −608 | $159.40 | $97K | 376 |
| 2024-06-17 | OYLER JOHN Chief Executive Officer | Sale | −376 | $159.91 | $60K | 0 |
| 2024-06-17 | Wang Julia Aijun Chief Financial Officer | Sale | −154 | $158.24 | $24K | 762 |
| 2024-06-17 | Wang Julia Aijun Chief Financial Officer | Sale | −195 | $158.58 | $31K | 567 |
| 2024-06-17 | Wang Julia Aijun Chief Financial Officer | Sale | −253 | $159.00 | $40K | 314 |
| 2024-06-17 | Wang Julia Aijun Chief Financial Officer | Sale | −314 | $159.74 | $50K | 0 |
| 2024-06-17 | Wang Lai Global Head of R&D | Sale | −237 | $158.50 | $38K | 2,104 |
| 2024-06-17 | Wang Lai Global Head of R&D | Sale | −478 | $159.00 | $76K | 1,626 |
| 2024-06-17 | Wang Lai Global Head of R&D | Sale | −485 | $159.42 | $77K | 1,141 |
| 2024-06-17 | Wang Lai Global Head of R&D | Sale | −300 | $159.90 | $48K | 841 |
| 2024-06-17 | Wu Xiaobin President, COO & GM China | Sale | −627 | $159.00 | $100K | 2,627 |
| 2024-06-17 | Lee Chan Henry SVP, General Counsel | Sale | −102 | $158.20 | $16K | 337 |
| 2024-06-17 | Lee Chan Henry SVP, General Counsel | Sale | −208 | $159.68 | $33K | 129 |
| 2024-06-17 | Lee Chan Henry SVP, General Counsel | Sale | −129 | $159.74 | $21K | 0 |
Page 38 of 71 · 1,406 trades